No Data
No Data
Hong Kong stocks have fluctuated | WiseCloud Health rose more than 5% and obtained the exclusive commercialization rights of two plant-based drugs under the German pharmaceutical company Merck.
China Yun Health (9955.HK) rose by over 5%, closing at 1.23 Hong Kong dollars. On the news front, recently, China Yun Health signed a strategic cooperation agreement with the German family medicine company Medice Health Family.
Abnormal statistics of the proportion of ChiNext Stock Connect on September 11th.
Smart Communications Stock Connect Proportion Anomaly Statistics | September 10, 2024
Zhixun Health [09955] is now trading at HKD 1.1, with a decrease of 11.29%.
As of 09:53, Zhiyun Health [09955] reported 1.1 Hong Kong dollars, a decrease of 0.14 Hong Kong dollars or 11.29% from yesterday's closing price of 1.24 Hong Kong dollars. The transaction amount was 0.6403 million Hong Kong dollars. The highest price today was 1.24 Hong Kong dollars, and the lowest price was 1.1 Hong Kong dollars. Based on yesterday's closing price, the 10-day average price was 3.22 Hong Kong dollars, and the 50-day average price was 2.98 Hong Kong dollars. The current P/E ratio is -4.43 times, and the 14-day relative strength index is 39.67.
Hong Kong Stock Exchange Announcement | Bank of Zhengzhou intends to sell assets held by Zhongyuan Assets for 10 billion yuan.
Zhiyun Health (09955) has obtained the exclusive rights in China for the importation, distribution, sales, and promotion of Livemin and Shibao Litong tablets in hospitals and pharmacies for five years.
ClouDr Obtains Exclusive Rights to Sell Menopause, Cold Drugs by German Firm
ClouDr Group Secures Strategic Alliance With Medice
No Data
No Data